Baleva Marta P, Karagyozova Zhivka P, Nikolova-Vlahova Milena K, Nikolov Krasimir V, Nikolov Petar K
Medical University-Sofia, University Hospital Alexandrovska, Sofia, Bulgaria.
Medical University-Sofia, University Hospital Majchin Dom, Sofia, Bulgaria.
Cent Eur J Immunol. 2014;39(3):352-6. doi: 10.5114/ceji.2014.45947. Epub 2014 Oct 14.
Seventy-six female patients with two or more recurrent pregnancy losses (RPL) during the 1(st) trimester were studied. Based on the results of the aCL and aB2GPI antibodies testing, patients were divided in two groups: 22 patients with RPL and elevated immunoglobulin (Ig) G/IgM aCL and/or aB2GPI [RPL + antiphospholipid syndrome (APS)] and 54 patients with RPL alone (without high antibodies). Immunoglobulin G aPS and IgG a-AnV in patients with RPL + APS were higher than in controls and IgG aPS were higher in RPL + APS than in RPL alone. Additionally IgG a-AnV and IgM aPE are higher in RPL alone than in controls. In 18/22 (81%) patients with RPL + APS and 29/54 (54%) patients with RPL alone, there were one or more positive antibodies: aPS, aPT, a-AnV or aPE. These results raise a question whether or not these antiphospholipid antibodies should be routinely tested in women with RPL and especially in the context of the so-called "seronegative APS".
对76名在孕早期有两次或更多次复发性流产(RPL)的女性患者进行了研究。根据抗心磷脂抗体(aCL)和抗β2糖蛋白I抗体(aB2GPI)检测结果,将患者分为两组:22名患有RPL且免疫球蛋白(Ig)G/IgM aCL和/或aB2GPI升高的患者[RPL + 抗磷脂综合征(APS)]和54名单纯RPL患者(无高抗体)。RPL + APS患者的IgG抗磷脂抗体(aPS)和IgG抗心内膜抗体(a - AnV)高于对照组,且RPL + APS患者的IgG aPS高于单纯RPL患者。此外,单纯RPL患者的IgG a - AnV和IgM抗磷脂酰乙醇胺抗体(aPE)高于对照组。在18/22(81%)的RPL + APS患者和29/54(54%)的单纯RPL患者中,存在一种或多种阳性抗体:aPS、抗凝血酶原抗体(aPT)、a - AnV或aPE。这些结果提出了一个问题,即对于RPL女性,尤其是在所谓的“血清阴性APS”情况下,是否应该常规检测这些抗磷脂抗体。